Interestingly, EC-derived fibronectin expressing the EDA domain enhances the metastatic capacity of CRC cells inducing the epithelial–mesenchymal transition, highlighting the role of ECM in modulating a pro-active role of EC on tumor cell behavior [76]. This evidence concerns the gene FN1 and neoplasm.